Possible talks with the FDA regarding a minimum of four indications with our completed phase 2 drugs may be close to finalisation
The fact that we received a positive way forward for a NEW indication may bode well for the others
Look forward to some possible announcements soon
Fortunately the significance of the 505(B)(2) news has not been understood by Mr Market,which has enabled us long term holders to purchase more shares quietly at in my opinion a ridiculously low level
Looking forward to further announcements regarding 505(B)(2)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
12.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $52.27M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4200 | 12.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.5¢ | 108148 | 2 |
View Market Depth
| Last trade - 16.21pm 11/09/2025 (20 minute delay) ? |
| SPL (ASX) Chart |
Day chart unavailable